Inquiry points to maker and lab in fatal French drug trial: reports

PARIS (Reuters) - An official investigation into a clinical drug trial that left one person dead and five others hospitalized in France in January pointed to both the laboratory and the maker for committing errors in the testing process, two dailies said.

House approves $622 million to combat Zika virus

WASHINGTON (Reuters) - The U.S. House of Representatives passed a bill on Wednesday to provide $622.1 million to control the spread of the Zika virus, far below President Barack Obama's request and lower than Senate legislation.

Senate set to approve $1.1 billion in Zika virus funding

WASHINGTON (Reuters) - The U.S. Senate on Tuesday cleared the way for approval of $1.1 billion in immediate funds to battle the Zika virus that is linked to birth defects, well above what is in legislation pending in the House of Representatives.

Magic mushroom ingredient may ease severe depression, study suggests

LONDON, May 17 (Reuters) - Psilocybin, the psychedelic compound in magic mushrooms, may one day be an effective treatment for patients with severe depression who fail to recover using other therapies, scientists said on Tuesday.

Australia's Starpharma, Ansell to supply anti-Zika condoms for Olympics

SYDNEY (Reuters) - Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.

Pfizer blocks its drugs from use in lethal injections

NEW YORK (Reuters) - - Pfizer Inc has taken steps to ensure that none of its products are used in lethal injections, the largest U.S. drugmaker said on Friday.

U.S. CDC announces funds to fight Zika locally

(Reuters) - The U.S. health department has made available more than $85 million to fight Zika infection in the country, the Centers for Disease Control and Prevention (CDC) said on Friday.